UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018723
Receipt number R000021661
Scientific Title Analysis of MRSA transmission by the genetic methods
Date of disclosure of the study information 2015/08/19
Last modified on 2015/08/20 13:48:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of MRSA transmission by the genetic methods

Acronym

genetic analysis of MRSA

Scientific Title

Analysis of MRSA transmission by the genetic methods

Scientific Title:Acronym

genetic analysis of MRSA

Region

Japan


Condition

Condition

MRSA

Classification by specialty

Medicine in general Infectious disease

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To analyze the MRSa transmisson by the genetic analysis

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

MRSA type, Trasmission confirmation at 3 months after intervention.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

MRSA de-colonaization (mupirocin 5 days), Ns education (every week, lecture): Total 3 months intervention

Interventions/Control_2

None

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

MRSA positive patents, such as nasal samples on admission and the other samples after admission including blood.

Key exclusion criteria

Children

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masafumi Seki

Organization

Tohoku Pharmaceutical University Hospital

Division name

Respiratory and ID

Zip code


Address

Sendai

TEL

81-22-259-1221

Email

seki@hosp.tohoku-pharm.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masafumi Seki

Organization

Tohoku Pharmaceutical University Hospital

Division name

Respiratory and ID

Zip code


Address

Sendai

TEL

81-22-259-1221

Homepage URL


Email

seki@hosp.tohoku-pharm.ac.jp


Sponsor or person

Institute

Tohoku Pharmaceutical University Hospital

Institute

Department

Personal name



Funding Source

Organization

Scientific Research fund

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 08 Month 19 Day

Date of IRB


Anticipated trial start date

2015 Year 08 Month 19 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 08 Month 19 Day

Last modified on

2015 Year 08 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021661


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name